## **Core Concept**
Behcet's syndrome is a form of vasculitis that affects blood vessels throughout the body, leading to a wide range of symptoms including oral ulcers, genital ulcers, skin lesions, and ocular involvement. The treatment of Behcet's syndrome often involves immunosuppressive and anti-inflammatory agents to manage its manifestations.

## **Why the Correct Answer is Right**
The correct answer involves the use of **Glucocorticoids**. Glucocorticoids are potent anti-inflammatory agents that are commonly used as a first-line treatment for Behcet's syndrome to control acute flare-ups and reduce inflammation. They can be used alone for mild disease or in combination with other immunosuppressive drugs for more severe cases.

## **Why Each Wrong Option is Incorrect**
- **Option A: Vincristine** - Vincristine is a chemotherapeutic agent used primarily in the treatment of various cancers. It works by inhibiting microtubule formation in the mitotic spindle, resulting in cell cycle arrest at metaphase. It is not typically used in the treatment of Behcet's syndrome.
- **Option B: Aspirin** - Aspirin is a nonsteroidal anti-inflammatory drug (NSAID) with antiplatelet properties. While it may provide symptomatic relief for some aspects of Behcet's syndrome, such as pain from ulcers or arthritis, it does not address the underlying inflammatory process and is not a primary treatment.
- **Option D: Thalidomide** - Thalidomide has been used in the treatment of certain complications of Behcet's syndrome, particularly for severe, refractory mucocutaneous lesions. However, due to its teratogenic effects and side effect profile, it is not a first-line treatment and is considered for specific indications.

## **Clinical Pearl / High-Yield Fact**
A key point to remember is that the treatment of Behcet's syndrome is highly individualized based on the specific manifestations and severity of the disease. **Glucocorticoids** are often a cornerstone of treatment for their broad anti-inflammatory effects.

## **Correct Answer: C. Glucocorticoids**